Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor models
C. P. Kerr, J. Sheehan-Klenk, J. J. Grudzinski, D. P. Adam, T. P. T. Nguyen, C. de Aguiar Ferreira, A. M. Bates, W. J. Jin, O. Kwon, A. P. Olson, W. Lin, M. Hyun, J. C. Jagodinsky, M. Powers, R. N. Sriramaneni, , Z. S. Morris
This study examines how different radionuclides affect the type I interferon response in tumor models and shows that 225Ac enhances immunotherapy response via STING-dependent mechanisms.
bioRxiv · Jul 10, 2024 · PreprintCancer Biology